jcserc mentioned on the BSW thread: "New position on MFAPX. I certainly need foreign exposure in my portfolio as it is extremely low right now (single digits). This need is what motivated the whole rebalancing act. As a previous owner of Grandeur funds, I was almost ready to buy GISOX. Nonetheless, I am fairly impressed with the performance and risk profile of MFAPX and its manager...so decided to go with it (in reality, since that purchase is going to be done on Tuesday, I will still do more research between today and tomorrow)."
GISOX/GISYX is in SC/MC territory while MFAPX is LC ... I am not sure this pair is an "either - or" choice. There are many good foreign LC funds (I own VWILX, which cannot be beat on price; I also like APDYX/ARTYX which is EM-oriented). But not many SC/MC funds. I do happen to like GP, and have some money invested in three of their funds.
Thank you Chang for starting this thread. As I mentioned, I am still doing some due diligence, so comments are welcomed!
I had looked at ARTYX but it does have a 30% allocation to domestic stocks and I am looking for the fund to be almost exclusively in foreign markets given my low international allocation. I used to own both GGSOX and GPROX from Grandeur, so GISOX was the first one that came to my mind during this process (I do agree that comparing GISOX to MFAPX is not correct, as GISOX is in SC/MC territory). VWILX would be a good option, but my accounts are at Schwab, and don't like to pay transaction fees as I frequently add to my funds.
Nonetheless, it is hard to argue with the risk-reward profile of Kristian Heugh, manager of both MFAPX and MIOPX (I am actually giving MIOPX good consideration...the main difference is that it has a bit more emerging markets exposure):